Literature DB >> 14729397

Localization and variation of TRAIL and its receptors in human placenta during gestation.

LiHua Chen1, XueSong Liu, Yong Zhu, YunXin Cao, Lan Sun, BoQuan Jin.   

Abstract

The localization of TRAIL and its receptors in human placenta was studied under light microscopy using immunohistochemistry method. The variation of TRAIL and its receptors with development was also detected by in situ semi-quantification. The syncytiotrophoblast, cytotrophoblast, stromal cells and the capillary endothelium cells in human placenta all appeared to be TRAIL immunoreactive and the immunoreactive material was distributed on membrane and in cytoplasm with negative nuclei. During whole gestation there was no obvious variation of the staining of TRAIL. Although DR4, DR5, DcR1 and DcR2 can also be detected in the placenta throughout pregnancy, DR4 and DR5 staining increased with development whereas DcR1 and DcR2 staining decreased. Interestingly, at the beginning of the gestation DR4 and DR5 staining distributed on the cytotrophoblast mainly, whereas DcR1 and DcR2 mainly located in the syncytiotrophoblast cells. Collectively, these results suggest that human placenta may not only produce TRAIL but also be a TRAIL target organ, and that TRAIL/TRAILR system could take part in the self-homeostasis of placenta during whole gestation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729397     DOI: 10.1016/j.lfs.2003.07.044

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection.

Authors:  Piya Chaemsaithong; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Tamara Stampalija; Zhong Dong; Lami Yeo; Edgar Hernandez-Andrade; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-04-22

2.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

3.  Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage.

Authors:  K Rull; K Tomberg; S Kõks; J Männik; M Möls; M Sirotkina; S Värv; M Laan
Journal:  Placenta       Date:  2013-01-03       Impact factor: 3.481

4.  Circulating TRAIL shows a significant post-partum decline associated to stressful conditions.

Authors:  Giorgio Zauli; Lorenzo Monasta; Erika Rimondi; Liza Vecchi Brumatti; Oriano Radillo; Luca Ronfani; Marcella Montico; Giuseppina D'Ottavio; Salvatore Alberico; Paola Secchiero
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

5.  TRAIL Is Decreased Before 20 Weeks Gestation in Women with Hypertensive Disorders of Pregnancy.

Authors:  Cheng Zhou; Yan Long; Hongling Yang; Chunyan Zhu; Qingling Ma; Yonggang Zhang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

6.  Molecular and biochemical investigations of key antioxidant/oxidant molecules in Saudi patients with recurrent miscarriage.

Authors:  Yazeed A Al-Sheikh; Hazem K Ghneim; Adel F Alharbi; Mashael M Alshebly; Feda S Aljaser; Mourad A M Aboul-Soud
Journal:  Exp Ther Med       Date:  2019-10-07       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.